标题：赛默飞贷款15亿美元支持Patheon收购计划

纽约——赛默飞世尔科技上周宣布开始了一项无抵押定期贷款，总金额15亿美元，期限为364天。

该款项将用于完成赛默飞对合同开发与制造商Patheon的收购计划，该计划共计将投入约72亿美元，包括偿还Patheon的债务以及收购产生的交易费用。

赛默飞在其提交美国证券交易委员会的文件中称，此债务关系建立在赛默飞世尔、美国银行以及贷款方之间，美国银行作为行政代理机构，美林证券（Merrill Lynch, Pierce, Fenner & Smith）是唯一的首席牵头人及账簿管理人。

此前，赛默飞于五月宣布了对Patheon的收购计划，并在上周宣布公开发售15亿美元股票以支持收购案的推进。按照一般程序，预计将在2017年三季度末全部完成。

原文：Thermo Fisher Scientific Enters Into $1.5B Loan Facility

NEW YORK (GenomeWeb) – Thermo Fisher Scientific said last week that it has entered into a 364-day unsecured term loan facility in the principal amount of $1.5 billion.

The company may use the proceeds of the loans to help fund the acquisition of Patheon, which is estimated to be approximately $7.2 billion in total. This includes repayment of Patheon's debt and transaction costs incurred in connection with the acquisition.

The debt facility was established between Thermo Fisher;Bank of America, acting as the administrative agent; the lenders party; and Merrill Lynch, Pierce, Fenner & Smith, who is the sole lead arranger and sole bookrunner, Thermo Fisher said in a document filed with the US Securities and Exchange Commission.

Thermo Fisher announced the Patheon deal in May. It is expected to close around the end of the third quarter of 2017, subject to customary closing conditions.

Also last week, Thermo Fisher priced an offering of $1.5 billion of senior notes, also to fund the acquisition of Patheon.

原文链接：